The hydroalcoholic extract of Salvia elegans induces anxiolytic- and antidepressant-like effects in rats

被引:42
作者
Mora, S [1 ]
Millán, R
Lungenstrass, H
Díaz-Véliz, G
Morán, JA
Herrera-Ruiz, M
Tortoriello, J
机构
[1] Univ Chile, Fac Med, Inst Ciencias Biomed, Programa Farmacol Mol & Clin,Lab Farmacol Comport, Santiago, Chile
[2] Univ Nacl Panama, Fac Med, Dept Farmacol, Panama City, Panama
[3] IMSS, Ctr Invest Biomed Sur, Xochipetec, Morelos, Mexico
关键词
Salvia elegans; anxiety; depression; forced swimming test; elevated plus-maze;
D O I
10.1016/j.jep.2005.12.004
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Behavioral effects of a hydroalcoholic (60% ethanol) extract from the leaves of Salvia elegans Vahl (Lamiaceae) were studied in male Sprague-Dawley rats. The extract was administered intraperitoneally and its effects on spontaneous motor activity (total motility, locomotion, rearing and grooming behavior) were monitored. Putative anxiolytic and antidepressant properties of Salvia elegans were studied in the elevated plus-maze test (EPM) and in the forced swimming test (FST), respectively. Deleterious effects of Salvia elegans on leaming and memory were also studied by using active and passive avoidance paradigms. The results revealed that all doses (3.12, 12.5, 25 and 50 mg/kg) of the extract caused a significant decrease in total motility, locomotion, rearing and grooming behavior. Only the dose of 12.5 mg/kg increased the exploration of the EPM open arms in a similar way to that of diazeparn (1 mg/kg). In the FST, all doses of the extract induced a reduction of immobility, in a similar way to that of fluoxetine (10 mg/kg) and imipramine (12.5 mg/kg), along with a significant increase in the time spent in swimming behavior. Acquisition of active avoidance responses was disrupted by pre-treatment with the extract, but retention of a passive avoidance response was not significantly modified. These results suggest that some of the components of the hydroalcoholic extract of Salvia elegans have psychotropic properties, which deserve further investigation. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:76 / 81
页数:6
相关论文
共 25 条
[1]  
Aguilar Contreras A, 1994, HERBARIO MED I MEXIC
[2]  
[Anonymous], 1997, HDB USE ANIMALS NEUR
[3]   Novel treatments for anxiety and depression: hurdles in bringing them to the market [J].
Buller, R ;
Legrand, V .
DRUG DISCOVERY TODAY, 2001, 6 (23) :1220-1230
[4]  
Clincke G.H.C., 1993, BEHAV NEUROSCIENCE P, VI, P71
[5]   Assessing antidepressant activity in rodents: recent developments and future needs [J].
Cryan, JF ;
Markou, A ;
Lucki, I .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2002, 23 (05) :238-245
[6]  
Cryan JF, 2000, J PHARMACOL EXP THER, V295, P1120
[7]   ACTIVE BEHAVIORS IN THE RAT FORCED SWIMMING TEST DIFFERENTIALLY PRODUCED BY SEROTONERGIC AND NORADRENERGIC ANTIDEPRESSANTS [J].
DETKE, MJ ;
RICKELS, M ;
LUCKI, I .
PSYCHOPHARMACOLOGY, 1995, 121 (01) :66-72
[8]   THE EFFECTS OF TRIAZOLOBENZODIAZEPINES IN 2 ANIMAL TESTS OF ANXIETY AND IN THE HOLEBOARD [J].
FILE, SE ;
PELLOW, S .
BRITISH JOURNAL OF PHARMACOLOGY, 1985, 86 (03) :729-735
[9]   Antidepressant effects of the herb salvia divinorum: A case report [J].
Hanes, KR .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2001, 21 (06) :634-635
[10]  
JANSSEN PAJ, 1965, ARZNEI-FORSCHUNG, V15, P1196